QA: Y mAbs Therapeutics Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001722964_2020_Y_mAbs_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001722964, Y mAbs Therapeutics Inc

  xvar xval
0 AssetsCurrent 211,955,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,052,000
3 remainder_Assets 2,359,000
4 LiabilitiesCurrent 13,586,000
5 LiabilitiesNoncurrent 1,956,000
6 remainder_Liabilities 1,921,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,512,000
9 ResearchAndDevelopmentExpense 63,492,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,976,000
13 remainder_ComprehensiveNetIncome 43,000
  yvar yval
0 Assets 216,366,000
1 Liabilities 17,463,000
2 Expenses 83,004,000
3 Revenues 0
4 StockholdersEquity 198,903,000
5 NetIncome -81,028,000
6 ComprehensiveNetIncome -81,006,500
7 BaseVar 159,426,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.02
9 EconomicCapitalRatio 3.70

Edgar->Model Mapping

Feature Distribution

Change over Time